OUTCOMES IN PATIENTS WITH B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA RECEIVING INOTUZUMAB OZOGAMICIN AND PROCEEDING TO HEMATOPOIETIC STEM CELL TRANSPLANTATION
M De-Limaa, P Kebriaeib, F Lanzac, C Chod, G Popradie, M Kaurf, M Zhangf, F Zhangg, E Vandendriesh, K Asomaningh, S Dormani, M Stelljesj, DI Marksk, A Curyl, W Saberf
a Ohio State University, Blood and Marrow and Cellular Therapy Program, Columbus, United States
b MD Anderson Cancer Center, Houston, United States
c Ospedale di Ravenna, Ravenna, Italy
d John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, USA
e McGill University Health Centre, Montreal, Canada
f Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, United States
g Pfizer Inc, Shanghai, China
h Pfizer Inc, Cambridge, United States
i Pfizer Inc, Ontario, Canada
j Universitätsklinikum Münster, Münster, Germany
k University Hospitals Bristol NHS Trust, Bristol, United Kingdom
l Pfizer Inc, São Paulo, Brazil
Ver másLido
731
Vezesque se leu este artigo
326
Total PDF
405
Total HTML
| Ano/Mês | Html | Total | |
|---|---|---|---|
| 2025 6 | 19 | 13 | 32 |
| 2025 5 | 38 | 9 | 47 |
| 2025 4 | 32 | 11 | 43 |
| 2025 3 | 35 | 9 | 44 |
| 2025 2 | 32 | 22 | 54 |
| 2025 1 | 21 | 17 | 38 |
| 2024 12 | 13 | 12 | 25 |
| 2024 11 | 20 | 16 | 36 |
| 2024 10 | 12 | 16 | 28 |
| 2024 9 | 19 | 19 | 38 |
| 2024 8 | 29 | 22 | 51 |
| 2024 7 | 19 | 17 | 36 |
| 2024 6 | 21 | 21 | 42 |
| 2024 5 | 22 | 26 | 48 |
| 2024 4 | 13 | 12 | 25 |
| 2024 3 | 21 | 12 | 33 |
| 2024 2 | 10 | 15 | 25 |
| 2024 1 | 4 | 10 | 14 |
| 2023 12 | 7 | 16 | 23 |
| 2023 11 | 12 | 21 | 33 |
| 2023 10 | 6 | 10 | 16 |
Mostrar tudo
